Premium
Subacute cutaneous lupus erythematosus after immunotherapy for renal‐cell carcinoma: the case for interferon‐alpha
Author(s) -
Lee H. Y.,
Pang S. M.
Publication year - 2010
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/j.1365-2230.2008.03157.x
Subject(s) - medicine , renal cell carcinoma , subacute cutaneous lupus erythematosus , alpha interferon , immunotherapy , lupus erythematosus , interferon , pathogenesis , dermatology , pathology , interferon alfa , systemic lupus erythematosus , immunology , connective tissue disease , autoimmune disease , disease , immune system , antibody
Summary Subacute cutaneous lupus erythematosus (SCLE) is a photosensitive dermatosis characterized by papulosquamous or annular lesions. It can be caused by a variety of medications. We report a case of SCLE in a patient after interferon‐α treatment for metastatic renal‐cell carcinoma and discuss the potential role of interferons in the pathogenesis of CLE.